✦ LIBER ✦

A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans

✍ Scribed by Kolida, S; Meyer, D; Gibson, G R

Book ID: 110024330
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 99 KB
Volume: 61
Category: Article
ISSN: 0954-3007
DOI: 10.1038/sj.ejcn.1602636

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute psychological and physiological ef

Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study

✍ Felix Hasler; Ulrike Grimberg; MarcoA. Benz; Theo Huber; FranzX. Vollenweider 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 316 KB

Neutralization of α2-antiplasmin by micr

Neutralization of α2-antiplasmin by microplasmin: A randomized, double-blind, placebo-controlled, ascending-dose study in healthy male volunteers

✍ Steve Pakola; Geraldine Cahillane; Jean-Marie Stassen; H. Roger Lijnen; Peter Ve 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Cervene in acute ischemic stroke: Result

Cervene in acute ischemic stroke: Results of a double-blind, placebo-controlled, dose-comparison study

✍ Wayne Clark; William Ertag; Edward Orecchio; Eric Raps 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 605 KB

A Single Dose of the Serotonin Neurotran

A Single Dose of the Serotonin Neurotransmission Agonist Paroxetine Enhances Motor Output: Double-Blind, Placebo-Controlled, fMRI Study in Healthy Subjects

✍ Isabelle Loubinoux; Jérémie Pariente; Kader Boulanouar; Christophe Carel; Claude 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 329 KB

Deramciclane in the treatment of general

Deramciclane in the treatment of generalized anxiety disorder: A placebo-controlled, double-blind, dose-finding study

✍ Hannu Naukkarinen; Roope Raassina; Jukka Penttinen; Antti Ahokas; Riitta Jokinen 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Escitalopram in the treatment of general

Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose study

✍ Jonathan R.T. Davidson; Anjana Bose; Andrew Korotzer; Hongjie Zheng 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Escitalopram has been shown in clinical trials to improve anxiety symptoms associated with depression, panic disorder, and social anxiety disorder. This study was designed to evaluate the efficacy and tolerability of escitalopram in the treatment of generalized anxiety disorder (GAD). Outpatients (1